News

  • MIT News feature: detecting mutations could lead to earlier liver cancer diagnosis

    Monday, 03/27/2017

    MIT researchers have now developed a way to determine, by sequencing DNA of liver cells, whether those cells have been exposed to aflatoxin. This profile of mutations could be used to predict whether someone has a high risk of developing…

  • MIT News feature: cancer from chronic inflammation

    Friday, 08/07/2015

    Chronic inflammation caused by disease or exposure to dangerous chemicals has long been linked to cancer, but exactly how this process takes place has remained unclear. Now, a precise mechanism by which chronic inflammation can lead to cancer has been…

  • MIT news feature: identifying sources of DNA damage

    Wednesday, 04/01/2015

    In the 1970s, epidemiologists found that workers in factories using vinyl chloride, the key ingredient for PVC plastics, had unusually high rates of a rare form of liver cancer called angiosarcoma. Biologists later identified a mutation that appears to be…

  • MIT News feature: tautomerism

    Tuesday, 07/29/2014

    Fifteen years ago, MIT professor John Essigmann and colleagues from the University of Washington had a novel idea for an HIV drug. They thought if they could induce the virus to mutate uncontrollably, they could force it to weaken and…

  • Essigmann lab publishes PNAS paper on the link between tautomerism and mutagenesis

    Friday, 07/25/2014

    The new manuscript, titled "Tautomerism provides a molecular explanation for the mutagenic properties of the anti-HIV nucleoside 5-aza-5,6-dihydro-2′-deoxycytidine" has been published this week in the early edition of PNAS. The paper studies the mechanism of mutagenesis of the anti-HIV compound…

  • Essigmann Group Produces Cover Article in Chem. Res. in Tox.

    Monday, 08/19/2013

    Essigmann Group submits Journal Article Removal of N-Alkyl Modifications from N2-Alkylguanine and N4-Alkylcytosine in DNA by the Adaptive Response Protein AlkB to Chemical Research in Toxicology (CRT). The cover of CRTs August 2013 volume depicts AlkB Dealkylates N2-Alkylguanine and N4-Methylcytosine…